Janney Montgomery Scott’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20M Sell
51,785
-734
-1% -$272K 0.04% 450
2026
Q1
$15.4M Buy
52,519
+1,089
+2% +$358K 0.04% 423
2025
Q4
$18M Sell
51,430
-859
-2% -$290K 0.04% 403
2025
Q3
$16.9M Buy
52,289
+4,240
+9% +$1.32M 0.04% 417
2025
Q2
$18.7M Buy
48,049
+272
+0.6% +$109K 0.05% 354
2025
Q1
$20.8M Buy
47,777
+3,563
+8% +$1.43M 0.06% 319
2024
Q4
$16.3M Buy
+44,214
New +$18.5M 0.05% 398
2024
Q3
Sell
-27,725
Closed -$15M 2709
2024
Q2
$15M Sell
27,725
-728
-3% -$385K 0.05% 393
2024
Q1
$14.8M Buy
28,453
+1,519
+6% +$755K 0.04% 413
2023
Q4
$12.7M Sell
26,934
-47
-0.2% -$21.7K 0.04% 431
2023
Q3
$11.7M Sell
26,981
-544
-2% -$247K 0.04% 386
2023
Q2
$12.2M Buy
+27,525
New +$12.7M 0.04% 402
2023
Q1
Sell
-24,684
Closed -$12.7M 2592
2022
Q4
$12.7M Sell
24,684
-1,575
-6% -$800K 0.05% 356
2022
Q3
$11.9M Buy
+26,259
New +$12.6M 0.05% 337
2021
Q1
Sell
-21,183
Closed -$6.8M 2278
2020
Q4
$6.8M Buy
21,183
+1,500
+8% +$460K 0.03% 445
2020
Q3
$5.29M Sell
19,683
-890
-4% -$239K 0.03% 470
2020
Q2
$5.41M Buy
20,573
+2,206
+12% +$589K 0.03% 421
2020
Q1
$4.17M Sell
18,367
-1,851
-9% -$504K 0.03% 442
2019
Q4
$6.11M Buy
20,218
+1,535
+8% +$422K 0.04% 394
2019
Q3
$4.49M Sell
18,683
-2,373
-11% -$650K 0.03% 470
2019
Q2
$5.94M Buy
21,056
+2,978
+16% +$813K 0.05% 382
2019
Q1
$5.19M Buy
18,078
+614
+4% +$178K 0.04% 392
2018
Q4
$4.59M Buy
17,464
+2,883
+20% +$793K 0.04% 383
2018
Q3
$4M Sell
14,581
-658
-4% -$171K 0.03% 473
2018
Q2
$3.63M Sell
15,239
-819
-5% -$190K 0.03% 467
2018
Q1
$3.53M Buy
16,058
+1,704
+12% +$400K 0.04% 466
2017
Q4
$3.23M Sell
14,354
-41
-0.3% -$8.73K 0.03% 481
2017
Q3
$2.73M Buy
14,395
+560
+4% +$107K 0.03% 497
2017
Q2
$2.6M Buy
13,835
+1,572
+13% +$282K 0.03% 477
2017
Q1
$2.03M Buy
12,263
+895
+8% +$142K 0.03% 555
2016
Q4
$1.63M Buy
11,368
+1,196
+12% +$160K 0.02% 570
2016
Q3
$1.27M Buy
+10,172
New +$1.31M 0.02% 570
2016
Q2
Sell
-10,260
Closed -$1.43M 808
2016
Q1
$1.43M Sell
10,260
-2,606
-20% -$348K 0.04% 430
2015
Q4
$1.79M Buy
12,866
+1,155
+10% +$159K 0.05% 375
2015
Q3
$1.64M Buy
11,711
+518
+5% +$77.8K 0.05% 381
2015
Q2
$1.84M Buy
11,193
+741
+7% +$118K 0.04% 518
2015
Q1
$1.61M Sell
10,452
-2,087
-17% -$297K 0.03% 653
2014
Q4
$1.58M Buy
12,539
+373
+3% +$46.1K 0.03% 646
2014
Q3
$1.46M Sell
12,166
-1,424
-10% -$163K 0.03% 659
2014
Q2
$1.46M Sell
13,590
-190
-1% -$19.6K 0.03% 633
2014
Q1
$1.37M Sell
13,780
-274
-2% -$24.8K 0.03% 621
2013
Q4
$1.3M Sell
14,054
-1,269
-8% -$113K 0.03% 607
2013
Q3
$1.28M Buy
15,323
+10,895
+246% +$934K 0.04% 539
2013
Q2
$362K Buy
+4,428
New +$331K 0.04% 482

Other funds holding ELV

Janney Montgomery Scott's ELV Position: Q2 2026 in Review

Janney Montgomery Scott reduced its Elevance Health (ELV) stake by 1.4% in Q2 2026, selling an estimated $272K and leaving 51,785 shares worth $20M. The position accounts for 0.04% of the portfolio, ranked #450.

Janney Montgomery Scott first reported a position in ELV in Q2 2013 and has held it in 44 quarters since. The position peaked at $20.8M in Q1 2025. 1,602 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Janney Montgomery Scott held 51,785 shares of Elevance Health worth $20M as of Q2 2026.
  • Janney Montgomery Scott sold 734 Elevance Health shares in Q2 2026, an estimated $272K.
  • Elevance Health made up 0.04% of Janney Montgomery Scott's portfolio in Q2 2026, its #450 holding.
  • Janney Montgomery Scott first reported a position in Elevance Health in Q2 2013 and has held it in 44 quarters since.
  • Janney Montgomery Scott's Elevance Health position peaked at $20.8M in Q1 2025.
  • 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Janney Montgomery Scott's 13F filing for Q2 2026, filed 5 Aug 2026.